United Kingdom· GB-APID-18758711000001100
Daunorubicin 20mg powder for solution for infusion vials
A daunorubicin product containing daunorubicin, registered in United Kingdom by A A H Pharmaceuticals Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Daunorubicin is registered in 13 of 19 countries.
Countries holding a registration under ATC L01DB02 (daunorubicin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 6 of them publish a price we can compare per daily dose
Daunorubicin · ATC L01DB02
13 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Daunorubicin
- Manufacturer
- A A H Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01DB02
- ATC class
- Daunorubicin
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
440 interactions on record for daunorubicin.
Graded by severity as the source publishes them — 98 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Daunorubicin · interactions on record
440 records
- 98 severe
- 332 moderate
- 10 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Daunorubicin in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenCerubidin 20 mg Pulver till infusionsvätska, lösningSanofi AB
- BelgiumCerubidine 20 mgSanofi Belgium
- IrelandCerubidin 20 mg Powder for Concentrate for Solution for InfusionSanofi-Aventis Ireland Limited T/A SANOFI
- NorwayCerubidinSanofi-aventis Norge (3)
- United Statesdaunorubicin hydrochlorideMeitheal Pharmaceuticals Inc.
- FinlandCerubidinRhone-Poulenc Rorer A/S
- CanadaCERUBIDINESEARCHLIGHT PHARMA INC
- NetherlandsCerubidine 20mg, poeder en oplosmiddel voor oplossing voor injectieSanofi B.V.
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Daunoblastin
- Belgium · Cerubidine, Daunorubicine Hikma
- Germany · Daunoblastin
- Denmark · Daunorubicin ”hikma"
- Estonia · Daunoblastina
- Spain · Daunoblastina
- Finland · Daunorubicin Hikma
- France · Cerubidine, Daunorubicin Hikma
- Croatia · Daunoblastina
- Hungary · Daunoblastina
- Ireland · Cerubidin
- Italy · Daunoblastina
- Luxembourg · Cerubidine
- Netherlands · Cerubidine, Daunorubicine Hikma
- Norway · Cerubidin, Daunorubicin Hikma
- Portugal · Daunorrubicina Hikma
- Sweden · Cerubidin, Daunorubicin Hikma
- Slovakia · Daunoblastina
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8f8dd1d0-1a43-4ea4-830f-d6cbb99c2e61 GET /v1/drugs/8f8dd1d0-1a43-4ea4-830f-d6cbb99c2e61?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "18758711000001100",
"desc": "Daunorubicin 20mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)",
"form": "Powder for solution for infusion",
"vpid": "41785411000001102",
"source": "dmd",
"vtm_id": "773356007",
"strength": "20 mg",
"substance": "Daunorubicin",
"ingredient": "Daunorubicin hydrochloride",
"supplier_code": "3144701000001104"
}See everything about daunorubicin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.